Transarterial Chemoembolization in Hepatocellular Carcinoma: Lessons from a 10-Year Real-World Retrospective Study.

J Hepatocell Carcinoma · 2026 · PMC13281869 · PMID 42326605

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

These patients demonstrated poorer PFS (HR = 3.14, 95% CI: 2.07–4.78, p < 0.001), while the difference in OS did not reach statistical significance, although there was a trend towards reduced survival (HR = 1.57, 95% CI: 0.92–2.71, p = 0.096) ( Figure 3E and F ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.